AcquisitionOther
Harmony Biosciences Holdings, Inc. acquired Zynerba Pharmaceuticals, Inc
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Harmony Biosciences Holdings, Inc. -> Zynerba Pharmaceuticals, Inc · $1.1059
Dayno, MD, described its lead candidate, Zygel, as a ‘portfolio in a product’ with the potential to serve 80,000 U.S.
Open source record (SEC) ↗